References
Schnater JM, Köhler SE, Lamers WH, Von Schweinitz D, Aronson DC. Where do we stand with hepatoblastoma? A review. Cancer. 2003;98:668–78. https://doi.org/10.1002/cncr.11585.
López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27:472–91. https://doi.org/10.1038/modpathol.2013.80.
Steliarova-Foucher E, Colombet M, Ries LAGG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–31. https://doi.org/10.1016/S1470-2045(17)30186-9.
Celotti A, D’Amico G, Ceresoli M, Tomasoni M, Raimondo S, Baggi P, et al. Hepatoblastoma of the adult: a systematic review of the literature. Surg Oncol. 2016;25:339–47. https://doi.org/10.1016/j.suronc.2016.07.003.
Wang YX, Liu H. Adult hepatoblastoma: systemic review of the English literature. Dig Surg. 2012;29:323–30. https://doi.org/10.1159/000342910.
Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol. 2000;1:94–100. https://doi.org/10.1016/S1470-2045(00)00018-8.
Perilongo G, Shafford E. Liver tumours. Eur J Cancer. 1999;35:953–8. https://doi.org/10.1016/S0959-8049(99)00049-0.
Han YS, Kim MK, Yun DY, Oh HK, Kim BS, Lee CH, et al. A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult. Clin Mol Hepatol. 2015;21:300. https://doi.org/10.3350/cmh.2015.21.3.300.
Huang G, Shu L, Xu J. Heart failure and main pulmonary artery obstruction caused by right ventricular metastatic adult hepatoblastoma: a case report. Medicine (United States). 2015;94:25–6. https://doi.org/10.1097/MD.0000000000001535.
Celotti A, Baiocchi GL, Ceresoli M, Bartoli M, Ulinici S, Portolani N. Hepatoblastoma of the adult with pericardial metastasis: a case report. Int J Surg Case Rep. 2016;20:80–3. https://doi.org/10.1016/j.ijscr.2016.01.010.
Urdiain G, Sánchez Acedo P, Mateo Retuerta J, Castilla T, Ripa Z, Herrera Cabezón J. notas clínicas0 Hepatoblastoma del adulto. Presentación de un caso Adult hepatoblastoma. A case report. An Sist Sanit Navar. 2016;39:301–4.
van Gulik TM, Westermann AM, Phoa SSKS, Verheij J, Oomen M, de Bree K, et al. Two cases of hepatoblastoma in young adults. J Adolesc Young Adult Oncol. 2018;7:404–8. https://doi.org/10.1089/jayao.2017.0125.
Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18:2665–75. https://doi.org/10.1200/JCO.2000.18.14.2665.
Czauderna P, Mackinlay G, Perilongo G, Brown J, Shafford E, Aronson D, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol. 2002;20:2798–804. https://doi.org/10.1200/JCO.2002.06.102.
Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42:74–83. https://doi.org/10.1002/pbc.10376.
Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361:1662–70. https://doi.org/10.1056/NEJMoa0810613.
Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol. 2010;28:2584–90. https://doi.org/10.1200/JCO.2009.22.4857.
Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;14:834–42. https://doi.org/10.1016/S1470-2045(13)70272-9.
Czauderna P, Otte J-B, Roebuck DJ, von Schweinitz D, Plaschkes J. Surgical treatment of hepatoblastoma in children. Pediatr Radiol. 2006;36:187–91. https://doi.org/10.1007/s00247-005-0067-0.
De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44:545–50. https://doi.org/10.1016/j.ejca.2007.11.022.
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2009;53:1016–22. https://doi.org/10.1002/pbc.22088.
Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma — results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1. Eur J Cancer. 2000;36:1418–25. https://doi.org/10.1016/S0959-8049(00)00074-5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vishnoi, J.R., Sasidhar, A., Misra, S. et al. Hepatoblastoma in a Young Adult: a Rare Case Report and Review of the Literature. J Gastrointest Canc 51, 319–324 (2020). https://doi.org/10.1007/s12029-019-00256-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-019-00256-3